Interestingly, Gleixner et al. [52] recently reported that inhibiting PLK1 with BI 2536 could override imatinib resistance in chronic myeloid leukemia. The gene discussed is PLK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.